Management of preterm labor: atosiban or nifedipine?
- PMID: 21072306
- PMCID: PMC2971730
- DOI: 10.2147/ijwh.s7219
Management of preterm labor: atosiban or nifedipine?
Abstract
Preterm birth is strongly associated with neonatal death and long-term neurological morbidity. The purpose of tocolytic drug administration is to postpone threatening preterm delivery for 48 hours to allow maximal effect of antenatal corticosteroids and maternal transportation to a center with specialized neonatal care facilities. There is uncertainty about the value of atosiban (oxytocin receptor antagonist) and nifedipine (calcium channel blocker) as first-line tocolytic drugs in the management of preterm labor. For nifedipine, concerns have been raised about unproven safety, lack of placebo-controlled trials, and its off-label use. The tocolytic efficacy of atosiban has also been questioned because of a lack of reduction in neonatal morbidity. This review discusses the available evidence, the pros and cons of either drug and aims to provide information to support a balanced choice of first-line tocolytic drug: atosiban or nifedipine?
Keywords: atosiban; calcium channel blocker; nifedipine; oxytocin receptor antagonist; preterm birth; preterm labor; tocolytic drugs.
References
-
- Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360:1489–1497. - PubMed
-
- Hack M, Dandruff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990’s. Early Hum Dev. 1999;53 - PubMed
-
- Petrou S, Mehta Z, Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics. 2003;112:1290–1297. - PubMed
-
- Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B. Annual summary of vital statistics: 2004. Pediatrics. 2006;117:168–183. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
